Non-viral gene therapy offers hope for chronic low back pain sufferers

FHS
May 20, 2024
8:48 am

A novel non-viral gene therapy for discogenic back pain (DBP).

Asimov introduces its AI-driven 4th generation CHO Edge System with increased titer guarantee

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of its fourth generation CHO Edge System.

July 31, 2024

Antibody engineering drives innovation in drug development

Monoclonal antibodies (mAbs) are used to prevent, detect, and treat a broad spectrum of non-communicable and communicable diseases. Over the past few years, the market

October 16, 2024

It’s time to remove skin color from the Apgar Score for newborns

In medicine, inertia can be a strangely powerful force, but Virginia Apgar never succumbed to it. She brought incredible energy to her work in anesthesia,

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.